Investing in Global Healthcare

By Dale Van Demark, Michael Ryan, Stephen W. Bernstein, Kristian A. Werling, Hamid Yunis, Sharon Lamb, Emmanuelle Trombe and Dr. Stephan Rau on June 10, 2021

Posted In Digital Health, Health M&A, Health Private Equity, Life Sciences

Today’s global healthcare marketplace is marked by unprecedented transformation. This presents both challenges and opportunity to today’s market participants. We know how important it is to structure cross-border investments and transactions to account for complex and ever-shifting regulations.

Within this dynamic environment, our health lawyers wield a deep knowledge of how healthcare services, medical technology and pharmaceuticals are delivered around the world, and how the laws that affect those entities and that help drive action are creating the market of tomorrow.

Bringing this experience and commercial focus together we are proud to present the Global Guide to Investing in Healthcare. Our one-stop resource is here to guide you through the healthcare systems of key jurisdictions, helping you to explore the regulation and provision of healthcare services, merger and foreign investment control, anticipated changes in healthcare and life sciences law, and much more.

Click here to visit our interactive report, and start exploring the opportunities and challenges for your business today.

Tags: AI, Anti-Kickback Rules, COVID-19, Drug Approvals, Foreign Investment, Health Mergers and Acquisitions, Healthcare Services, medical devices, Reimbursement, Telehealth, Telemedicine

Dale Van Demark
With his robust experience in health system affiliations, joint venture transactions, cross-industry collaborations and the development of new healthcare delivery models, Dale C. Van Demark works at the forefront of strategic transactions and digital health matters in the health, life sciences and technology industries. As a sought-after legal, strategic and policy advisor, he’s well-informed on integrating information technology into healthcare and has worked with clients in the realms of delivery of care, life sciences research and development, and artificial intelligence. Read Dale's full bio.

Michael Ryan
Michael W. Ryan advises manufacturers, health care providers, developers, and investors on the legal, regulatory, and reimbursement issues that arise during the development and commercialization of medical devices, drugs, biological products, and clinical laboratory testing services. Read Michael Ryan's full bio.

Stephen W. Bernstein
Stephen W. Bernstein specializes in e-health, “big data,” deployment of electronic health record systems and health-related matters affected by the internet and the Health Insurance Portability and Accountability Act (HIPAA), as well as private equity investments, mergers, acquisitions, affiliations and joint ventures involving technology, hospitals and physicians. Stephen is the global head of McDermott's Health Practice. Read Stephen Bernstein's full bio.

Kristian A. Werling
Kristian (Krist) Werling is co-chair of the Firm’s Life Sciences Practice. He represents biopharmaceutical manufacturers and health care service providers in a wide variety of transactional matters. He also represents private equity and venture capital investors in investments in the life sciences and health care industries. In this capacity, he works with cross-disciplinary teams to conduct legal due diligence and execute acquisitions, add-on acquisitions and divestitures, as well as provide ongoing legal services to portfolio companies. In the health care services arena, Krist has particular experience with transactions and joint ventures involving ambulatory surgical centers, specialty hospitals, dermatology, pain management and anesthesia physician practices and dental practice management companies.

Hamid Yunis
Hamid Yunis advises clients on complex areas of transactional law (M&A, Investments, Private Equity, Major Projects and Corporate Finance) predominantly within the health industry and on infrastructure transactions. He has substantial global experience in innovative structures for complex joint ventures, public-private partnerships and funding arrangements. Hamid’s global client base includes health care providers, medical products manufacturers and organizations establishing “medical cities”, along with non-health clients where he advises on infrastructure projects and major projects. Hamid also has a particular interest in advising Sovereign Wealth Funds on their investments and other transactions.

Sharon Lamb
Sharon Lamb focuses her practice on transactional and regulatory advice in the health and life sciences sector. Sharon advises on global transactional mandates, including mergers and acquisitions and joint ventures in health services, pharma and life sciences, digital health and health data technologies. Read Sharon Lamb's full bio.

Emmanuelle Trombe

Dr. Stephan Rau

Investing in Global Healthcare

Related Posts

BLOG EDITORS

STAY CONNECTED

TOPICS

ARCHIVES

RECENT POSTS